FI113167B - Menetelmä osteoartikulaaristen sairauksien hoidossa käyttökelpoisten N-[(4,5-dihydroksi- ja 4,5,8-trihydroksi-9,10-dihydro-9,10-diokso-2-antrasenyyli)karbonyyli]aminohappojen valmistamiseksi - Google Patents

Menetelmä osteoartikulaaristen sairauksien hoidossa käyttökelpoisten N-[(4,5-dihydroksi- ja 4,5,8-trihydroksi-9,10-dihydro-9,10-diokso-2-antrasenyyli)karbonyyli]aminohappojen valmistamiseksi Download PDF

Info

Publication number
FI113167B
FI113167B FI933925A FI933925A FI113167B FI 113167 B FI113167 B FI 113167B FI 933925 A FI933925 A FI 933925A FI 933925 A FI933925 A FI 933925A FI 113167 B FI113167 B FI 113167B
Authority
FI
Finland
Prior art keywords
dihydro
dioxo
useful
preparation
dihydroxy
Prior art date
Application number
FI933925A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933925A (fi
FI933925A0 (fi
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Abiogen Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Srl filed Critical Abiogen Pharma Srl
Publication of FI933925A publication Critical patent/FI933925A/fi
Publication of FI933925A0 publication Critical patent/FI933925A0/fi
Application granted granted Critical
Publication of FI113167B publication Critical patent/FI113167B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI933925A 1991-03-12 1993-09-08 Menetelmä osteoartikulaaristen sairauksien hoidossa käyttökelpoisten N-[(4,5-dihydroksi- ja 4,5,8-trihydroksi-9,10-dihydro-9,10-diokso-2-antrasenyyli)karbonyyli]aminohappojen valmistamiseksi FI113167B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI910658 1991-03-12
ITMI910658A IT1244773B (it) 1991-03-12 1991-03-12 N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
EP9200479 1992-03-04
PCT/EP1992/000479 WO1992016496A1 (en) 1991-03-12 1992-03-04 N-[[4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections

Publications (3)

Publication Number Publication Date
FI933925A FI933925A (fi) 1993-09-08
FI933925A0 FI933925A0 (fi) 1993-09-08
FI113167B true FI113167B (fi) 2004-03-15

Family

ID=11359001

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933925A FI113167B (fi) 1991-03-12 1993-09-08 Menetelmä osteoartikulaaristen sairauksien hoidossa käyttökelpoisten N-[(4,5-dihydroksi- ja 4,5,8-trihydroksi-9,10-dihydro-9,10-diokso-2-antrasenyyli)karbonyyli]aminohappojen valmistamiseksi

Country Status (21)

Country Link
US (1) US5451606A (no)
EP (1) EP0588797B1 (no)
JP (1) JP2979054B2 (no)
KR (1) KR100224330B1 (no)
AT (1) ATE134363T1 (no)
AU (1) AU661475B2 (no)
CA (1) CA2105683C (no)
CZ (1) CZ282997B6 (no)
DE (1) DE69208464T2 (no)
DK (1) DK0588797T3 (no)
ES (1) ES2084348T3 (no)
FI (1) FI113167B (no)
GR (1) GR3019069T3 (no)
HU (1) HU215436B (no)
IT (1) IT1244773B (no)
MX (1) MX9201055A (no)
NO (1) NO304592B1 (no)
PT (1) PT100216B (no)
RU (1) RU2111959C1 (no)
SK (1) SK280134B6 (no)
WO (1) WO1992016496A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ245989A (en) * 1992-02-28 1995-02-24 Lilly Industries Ltd Anthraquinone derivatives and pharmaceutical compositions
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
IT1276781B1 (it) * 1995-06-23 1997-11-03 Gentili Ist Spa Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie
GB2398780A (en) * 2003-02-26 2004-09-01 Arakis Ltd 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as inhibitors of T-cell proliferation for treatment of autoimmune or inflammatory conditions
CN102060809B (zh) * 2009-05-01 2015-05-20 常州高新技术产业开发区三维工业技术研究所有限公司 一种大黄酸衍生物及其制备和用途
CN102225913B (zh) * 2011-04-07 2013-09-04 栗进才 大黄酸衍生物以及它们的治疗用途
RU2466134C1 (ru) * 2011-06-24 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Иркутский государственный университет" Способ получения катионных комплексов палладия
CN104557603A (zh) * 2014-12-08 2015-04-29 石河子大学 一种大黄酸类化合物及制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
US4966918A (en) * 1989-01-27 1990-10-30 Sloan-Kettering Institute For Cancer Research Derivatives of chryosphanol

Also Published As

Publication number Publication date
ES2084348T3 (es) 1996-05-01
DE69208464T2 (de) 1996-07-11
CA2105683A1 (en) 1992-09-13
PT100216A (pt) 1993-05-31
KR100224330B1 (ko) 1999-10-15
PT100216B (pt) 1999-06-30
CA2105683C (en) 2003-09-16
HU9302510D0 (en) 1993-12-28
GR3019069T3 (en) 1996-05-31
DK0588797T3 (da) 1996-06-17
NO933241L (no) 1993-09-10
HUT65218A (en) 1994-05-02
CZ282997B6 (cs) 1997-12-17
CZ182993A3 (en) 1994-07-13
NO933241D0 (no) 1993-09-10
EP0588797B1 (en) 1996-02-21
RU2111959C1 (ru) 1998-05-27
FI933925A (fi) 1993-09-08
JPH10502050A (ja) 1998-02-24
AU1359692A (en) 1992-10-21
IT1244773B (it) 1994-08-08
ATE134363T1 (de) 1996-03-15
SK280134B6 (sk) 1999-08-06
ITMI910658A0 (it) 1991-03-12
JP2979054B2 (ja) 1999-11-15
FI933925A0 (fi) 1993-09-08
AU661475B2 (en) 1995-07-27
NO304592B1 (no) 1999-01-18
SK94793A3 (en) 1994-03-09
HU215436B (hu) 1999-09-28
ITMI910658A1 (it) 1992-09-12
MX9201055A (es) 1992-09-01
EP0588797A1 (en) 1994-03-30
DE69208464D1 (en) 1996-03-28
US5451606A (en) 1995-09-19
WO1992016496A1 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
Shanbhag et al. Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity, and gastrointestinal toxicity
JP3231042B2 (ja) ２−（２，６−ジ−ハロ−フェニルアミノ）フェニル酢酸の誘導体の硝酸エステルおよびその製造法
NO142172B (no) Analogifremgangsmaate for fremstilling av som antikonvulsiva virksomme alfa-fenyl-benzyliden-aminosyrederivater
TWI230162B (en) Geranyl group-containing compounds
FI113167B (fi) Menetelmä osteoartikulaaristen sairauksien hoidossa käyttökelpoisten N-[(4,5-dihydroksi- ja 4,5,8-trihydroksi-9,10-dihydro-9,10-diokso-2-antrasenyyli)karbonyyli]aminohappojen valmistamiseksi
TW200407310A (en) Compounds
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
JPS6383053A (ja) 環状脂肪族アルコールのアミノ酸エステル類、その製法と医薬組成物
KR860001887B1 (ko) 글루타민 유도체의 제조방법
FI104166B (fi) Menetelmä lääkeianeina käyttökelpoisten 4,5-dihydroksi-9,10-dihydro-9,10-diokso-2-antraseenikarboksyylihapon aryylialkyyliesterien valmistamiseksi
JPH05504970A (ja) 尿素誘導体類、それらの製造およびそれらを含有している薬用生成物
JP2003506317A (ja) Ｌｔａ４ヒドロラーゼ抑制剤
JP3490114B2 (ja) 軟骨保護剤
JPS5892646A (ja) ベンジリデン誘導体
JPH04178359A (ja) テトラサイクリン誘導体
JP3093280B2 (ja) フェニルアセトアミド誘導体
CN108191733B (zh) 一种苯-吡咯戊烷类化合物、其制备方法及抗肝纤维化用途
JPH05125038A (ja) フエノキシアルカン酸誘導体及びその製法
JPH0454160A (ja) テトラサイクリン誘導体
HU219346B (en) N-[(4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-anthracenyl)-carbonyl]-amino acids and pharmaceutical compositions containing the same
LU81146A1 (fr) Esters benzylideniques et leur application en therapeutique
IE45519B1 (en) Sulfur-containing n-(o-aminobenzyl)-amino acids and esters
CA1105053A (fr) Sulfamido acetyleniques de benzamides utilisables en therapeutique
JPS61289079A (ja) マロン酸誘導体
FR2696456A1 (fr) Dérivés de dihydro-1,2 oxo amino-3 quinoxalines, leur préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ABIOGEN PHARMA S.R.L.

MA Patent expired